These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2363947)

  • 1. Systemic therapy of metastatic breast cancer.
    Rose C
    Acta Oncol; 1990; 29(3):361-5. PubMed ID: 2363947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine management of advanced breast cancer.
    Rose C; Mouridsen HT
    Horm Res; 1989; 32 Suppl 1():189-96; discussion 197. PubMed ID: 2693326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine therapy of advanced breast cancer.
    Rose C; Mouridsen HT
    Acta Oncol; 1988; 27(6A):721-8. PubMed ID: 3064777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen therapy of metastatic breast cancer.
    Manni A
    J Lab Clin Med; 1987 Mar; 109(3):290-9. PubMed ID: 2950193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR.
    Generali D; Corona SP; Pusztai L; Rouzier R; Allevi G; Aguggini S; Milani M; Strina C; Frati A
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):601-606. PubMed ID: 29344722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical benefit of sequential use of endocrine therapies for metastatic breast cancer.
    Iwase H; Yamamoto Y
    Int J Clin Oncol; 2015 Apr; 20(2):253-61. PubMed ID: 25673474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer.
    Buzdar AU
    Oncologist; 2003; 8(4):335-41. PubMed ID: 12897330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete estrogen blockade for the treatment of metastatic and early stage breast cancer.
    Michaud LB; Buzdar AU
    Drugs Aging; 2000 Apr; 16(4):261-71. PubMed ID: 10874521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination chemo-endocrine therapy of metastatic and stage IV breast cancer with cyclophosphamide, adriamycin, prednisolone and tamoxifen (CAPT)--with special reference to management of brain and liver metastasis].
    Nakamura Y; Kawaguchi M; Hata A; Watanabe H; Ueki Y; Oribe T; Koba F; Takamuku K
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):243-50. PubMed ID: 2919892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen in the treatment of breast cancer.
    Legha SS
    Ann Intern Med; 1988 Aug; 109(3):219-28. PubMed ID: 3291659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined antiestrogen and cytotoxic therapy with pseudomonas vaccine immunotherapy for metastatic breast cancer. A prospective, randomized trial.
    Hortobagyi GN; Buzdar AU; Frye D; Hug V; Fraschini G; Ames FC; Montague E; Gutterman JU; Martin RG
    Cancer; 1987 Dec; 60(11):2596-604. PubMed ID: 3315173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Present status of endocrine therapy of breast cancer: a surgeon's view].
    Nomura Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):981-8. PubMed ID: 6426405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up.
    Bontenbal M; Foekens JA; Lamberts SW; de Jong FH; van Putten WL; Braun HJ; Burghouts JT; van der Linden GH; Klijn JG
    Br J Cancer; 1998; 77(1):115-22. PubMed ID: 9459155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer of the breast].
    Maugard-Louboutin C
    Pathol Biol (Paris); 1992 Dec; 40(9 Pt 2):949-55. PubMed ID: 1363891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metastatic breast cancer: controlled treatment trial of chemotherapy combined with hormone therapy using medroxyprogesterone alone or combined with tamoxifen].
    Jouve M; Palangie T; Bretaudeau B; Garcia-Giralt E; Asselain B; Magdelenat H; Pouillart P
    Bull Cancer; 1984; 71(2):148. PubMed ID: 6733294
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemo-endocrine therapy of advanced breast cancer].
    Nomura Y
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3214-20. PubMed ID: 2973769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metastatic breast cancer: what are the objectives?].
    Salvini P; Ripa C; Ginanni V
    Tumori; 2000; 86(5 Suppl 1):S22-8. PubMed ID: 11195289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy versus combination of chemotherapy and endocrine therapy in advanced breast cancer. A prospective randomized study.
    Cocconi G; De Lisi V; Boni C; Mori P; Malacarne P; Amadori D; Giovanelli E
    Cancer; 1983 Feb; 51(4):581-8. PubMed ID: 6336981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete remission following endocrine or combined cytotoxic and hormonal treatment in advanced breast cancer. A retrospective analysis.
    Pedrazzini A; Cavalli F; Brunner KW; Goldhirsch A; Mermillod B
    Oncology; 1987; 44(1):51-9. PubMed ID: 3550556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiprolactinemic approach in the treatment of metastatic breast cancer: a phase II study of polyneuroendocrine therapy with LHRH-analogue, tamoxifen and the long-acting antiprolactinemic drug cabergoline.
    Lissoni P; Vaghi M; Villa S; Bodraska A; Cerizza L; Tancini G; Gardani GS
    Anticancer Res; 2003; 23(1B):733-6. PubMed ID: 12680176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.